Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Sell
1,138
-1,978
-63% -$677K 0.41% 55
2026
Q1
$1.03M Buy
3,116
+11
+0.4% +$3.92K 0.33% 52
2025
Q4
$1.02M Sell
3,105
-397
-11% -$126K 0.24% 69
2025
Q3
$988K Buy
+3,502
New +$1.02M 0.24% 71
2025
Q2
Sell
-3,852
Closed -$1.2M 90
2025
Q1
$1.2M Sell
3,852
-1,519
-28% -$449K 0.34% 62
2024
Q4
$1.59M Buy
5,371
+2,716
+102% +$806K 0.44% 44
2024
Q3
$856K Buy
2,655
+141
+6% +$46.1K 0.26% 75
2024
Q2
$786K Buy
2,514
+295
+13% +$86.7K 0.24% 80
2024
Q1
$631K Buy
+2,219
New +$649K 0.3% 28
2023
Q3
$619K Sell
2,303
-27
-1% -$6.74K 0.36% 45
2023
Q2
$517K Buy
2,330
+45
+2% +$10.4K 0.3% 54
2023
Q1
$552K Buy
+2,285
New +$561K 0.33% 52
2022
Q4
Sell
-2,271
Closed -$512K 127
2022
Q3
$512K Buy
2,271
+176
+8% +$42.7K 0.37% 51
2022
Q2
$510K Buy
+2,095
New +$513K 0.35% 57
2021
Q4
$648K Buy
+2,251
New +$475K 0.77% 21

Other funds holding AMGN

Tradewinds LLC's AMGN Position: Q2 2026 in Review

Tradewinds LLC reduced its Amgen (AMGN) stake by 63% in Q2 2026, selling an estimated $677K and leaving 1,138 shares worth $1.81M. The position accounts for 0.41% of the portfolio, ranked #55.

Tradewinds LLC first reported a position in AMGN in Q4 2021 and has held it in 15 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Tradewinds LLC held 1,138 shares of Amgen worth $1.81M as of Q2 2026.
  • Tradewinds LLC sold 1,978 Amgen shares in Q2 2026, an estimated $677K.
  • Amgen made up 0.41% of Tradewinds LLC's portfolio in Q2 2026, its #55 holding.
  • Tradewinds LLC first reported a position in Amgen in Q4 2021 and has held it in 15 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Tradewinds LLC's 13F filing for Q2 2026, filed 14 Aug 2026.